Back to News
News

VIP (Vasoactive Intestinal Peptide): What the Research Shows

23 May 2026By Pure Chems Research Team 1 min read
VIP (Vasoactive Intestinal Peptide): What the Research Shows

Research Use Only: This article summarises published scientific literature for laboratory and research audiences. It is not medical advice, and VIP is not approved for human or veterinary use in this context.

What is VIP?

VIP (vasoactive intestinal peptide) is a naturally occurring 28-amino-acid neuropeptide that acts as a signalling molecule in the nervous, immune and endocrine systems. It is studied in the neuroscience and immunology research literature.

Where VIP sits in the research literature

VIP has an extensive research literature spanning cell and animal studies. The material supplied here is intended for laboratory research use.

Reported areas of research interest

  • VPAC receptor signalling: studied at the VPAC1 and VPAC2 G-protein-coupled receptors in laboratory models.
  • Immune and neuroendocrine pathways: examined for effects on T-cell and inflammatory signalling in immunology research.

Why the “research use only” label matters

The VIP supplied here is a research material and is intended strictly for laboratory and scientific research, not for human or veterinary consumption.

Handling and storage

Store lyophilised peptide cool, dry and away from light, and refrigerate reconstituted solution, using it within the indicated stability window. Follow the documentation supplied with each batch.

Frequently asked questions

What is VIP studied for?

It is studied at the VPAC receptors and in immune and neuroendocrine research models.

Is VIP approved for human use?

The material supplied here is a research chemical only and is not intended for human or veterinary use.

Key takeaways

VIP is a naturally occurring neuropeptide with an extensive research literature in neuroscience and immunology. It is supplied as a research material only. Browse related research compounds in our full catalog.

References

References sourced via PubMed.

  1. Dorsam G, Goetzl EJ. Vasoactive intestinal peptide receptor-1 (VPAC-1) is a novel gene target of the hemolymphopoietic transcription factor Ikaros. J Biol Chem. 2002;277(16):13488-13493. DOI · PubMed 11812772.

Disclaimer: This article is for informational and educational purposes for a research audience. It is not medical advice. Products referenced are sold strictly for laboratory research and are not for human or veterinary use.

Research-grade compounds, verified purity

Every batch ships with a Certificate of Analysis. Explore the full PureChems catalog.

Browse the catalog